← Back to Patent Explorer
US3656483A Expired / Lapsed US ⏱️ 0.0 years remaining

Intrauterine medicator

Assignee: Biological Concepts Inc
•
Filing: 1970-01-15
•
Granted: 1972-04-18
•
Expires: 1990-01-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An intrauterine medicator and method for local application of medication to the uterus. The medicator includes a perforated tube containing a supply of medication; apparatus for maintaining medication adjacent the perforations for distribution to the uterine wall, and apparatus resiliently retaining the device in the uterus.

Inventors

  • 👤 Harry Rudel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:19
CPC Classifications
A; A61; A61M; A61M31/00; A61F; A61F6/00; A61F6/06; A61F6/14; A61F6/142

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 81 words
A device for the controlled release of a biologically active solid substance in the uterus, said device comprising a supply of said substance and a container therefor, said container being adaptable to containment within the uterine cavity and having perforations in a wall thereof, means within said container for urging said supply of solid substance into the vicinity of said perforations, and resilient retaining means affixed to an external wall of said container for retaining said device within the uterine cavity.
Claim 2
Independent Claim 81 words
A device for the controlled release of a biologically active solid substance in the uterus, said device comprising a supply of said substance and a container therefor, said container being adaptable to containment within the uterine cavity and having perforations in a wall thereof, means within said container for urging said supply of solid substance into the vicinity of said perforations, and resilient retaining means affixed to an external wall of said container for retaining said device within the uterine cavity.
Claim 3
Dependent Claim 15 words
A device as defined in claim 1 wherein said solid substance is an antifertility agent.
Claim 4
Dependent Claim 13 words
A device as defined in claim 1 wherein said antifertility agent is progesterone.
Claim 5
Dependent Claim 17 words
A device as in claim 1 wherein said biologically active substance is in the form of pellets.
Claim 6
Dependent Claim 48 words
A device as defined in claim 1 wherein said retaining means comprises, a pair of spring members mounted on said container, each of said spring members having a first end portion fixed to said container and an angularly related second end portion adapted to engage the uterine walls.
Claim 7
Dependent Claim 34 words
A device as defined in claim 1 wherein said retaining means comprises a first transverse arm and a second arm coplanar with said first arm and dependent therefrom, said second arm including said container.
Claim 8
Dependent Claim 109 words
An intrauterine medicator device for the controlled release of biologically active materials, said device comprising a container for said materials adaptablE to containment within the uterine cavity and having an elongated generally cylindrical side wall and opposed end wall members, said side wall having a plurality of perforations therein, a column of biologically active material retained within said container and adapted to be released through said perforations into the uterus, means within said container for urging said material towards said perforations and maintaining a supply thereof adjacent said perforations, and resilient retaining means affixed to an external wall of said container for retaining said device within the uterine cavity.
Claim 9
Dependent Claim 109 words
An intrauterine medicator device for the controlled release of biologically active materials, said device comprising a container for said materials adaptablE to containment within the uterine cavity and having an elongated generally cylindrical side wall and opposed end wall members, said side wall having a plurality of perforations therein, a column of biologically active material retained within said container and adapted to be released through said perforations into the uterus, means within said container for urging said material towards said perforations and maintaining a supply thereof adjacent said perforations, and resilient retaining means affixed to an external wall of said container for retaining said device within the uterine cavity.
Claim 10
Dependent Claim 77 words
A device as defined in claim 7 wherein said perforations are formed in said side wall at locations substantially intermediate said end walls, and said means for urging said material towards said perforations comprises a compression spring positioned within said container at each end thereof for bearing engagement with its associated end wall and the opposed end of said column whereby the central portion of said column is maintained adjacent said perforations during release of said material.
Claim 11
Dependent Claim 77 words
A device as defined in claim 7 wherein said perforations are formed in said side wall at one end thereof, and said means for urging said material towards said perforations comprises a compression spring positioned within said container in bearing relation between the other of said end walls and one end of said column to maintain the other end of said column adjacent said perforations and against said one wall during release of said biologically active material.
Claim 12
Dependent Claim 166 words
An intrauterine medicator device comprising, in combination, a generally cylindrical tube having closed end portions and formed of an inert material, said tube having a plurality of perforations adjacent one end portion thereof, a column of individual pellets of biologically active material contained within said tube, a compression spring positioned in said tube in bearing relation between the other end portion of said tube and one end of said column to urge said column towards said one end and to continuously maintain a portion of said column adjacent said perforations, a pair of spring members mounted on said container, each of said spring members having a first end portion fixed on said container and extending parallel to the longitudinal axis thereof and a second end portion diverging at an acute angle from said first portion adapted to engage the uterine walls to retain said device in the uterus, whereby body fluids leach said biologically active material through said perforations for local application to said uterine walls.
Claim 13
Dependent Claim 166 words
An intrauterine medicator device comprising, in combination, a generally cylindrical tube having closed end portions and formed of an inert material, said tube having a plurality of perforations adjacent one end portion thereof, a column of individual pellets of biologically active material contained within said tube, a compression spring positioned in said tube in bearing relation between the other end portion of said tube and one end of said column to urge said column towards said one end and to continuously maintain a portion of said column adjacent said perforations, a pair of spring members mounted on said container, each of said spring members having a first end portion fixed on said container and extending parallel to the longitudinal axis thereof and a second end portion diverging at an acute angle from said first portion adapted to engage the uterine walls to retain said device in the uterus, whereby body fluids leach said biologically active material through said perforations for local application to said uterine walls.
Claim 14
Dependent Claim 40 words
A device as defined in claim 10 wherein said second end portions of said spring members lie in parallel planes, tangent to said tube and extend in generally opposite directions whereby said spring members form an inverted V-shaped retaining means.
Claim 15
Dependent Claim 22 words
A device as defined in claim 11 including, a bearing pad positioned between said compression spring and one end of said column.

References Cited (Backward Citations)

US1605894A Cited
GB189413324A Cited
US1603767A Cited
US2122579A Cited
US2623841A Cited
US2962023A Cited
US3442266A Cited
US3409721A Cited
US3545439A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-04-18 1975-10-18 1976-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-04-18 1979-10-18 1980-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-04-18 1983-10-18 1984-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag